Open AccessPrescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project
Author(s) -
Ichihashi Kayo,
Hori Hikaru,
Hasegawa Naomi,
Yasuda Yuka,
Yamamoto Tomoya,
Tsuboi Takashi,
Iwamoto Kunihiro,
Kishimoto Taishiro,
Horai Tadasu,
Yamada Hiroki,
Sugiyama Nobuhiro,
Nakamura Toshinori,
Tsujino Naohisa,
Nemoto Kiyotaka,
Oishi Satoru,
Usami Masahide,
Katsumoto Eiichi,
Yamamori Hidenaga,
Tomita Hiroaki,
Suwa Taro,
Furihata Ryuji,
Inagaki Takahiko,
Fujita Junichi,
Onitsuka Toshiaki,
Miura Kenichiro,
Matsumoto Junya,
Ohi Kazutaka,
Matsui Yuki,
Takaesu Yoshikazu,
Hashimoto Naoki,
Iga Junichi,
Ogasawara Kazuyoshi,
Yamada Hisashi,
Watanabe Koichiro,
Inada Ken,
Hashimoto Ryota
Publication year - 2020
Publication title -
neuropsychopharmacology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 13
ISSN - 2574-173X
DOI - 10.1002/npr2.12122
Subject(s) - guideline , medicine , polypharmacy , medical prescription , schizophrenia (object oriented programming) , psychiatry , mood , psychotropic drug , antipsychotic , family medicine , drug , pharmacology , pathology
Background Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia. Methods A cross‐sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs. Results Forty‐three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers: 37%, anxiolytics or hypnotics: 68%). Conclusions In the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future.